# Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia

> **NCT00002499** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Grupo Argentino de Tratamiento de la Leucemia Aguda**

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** asparaginase
- **DRUG:** cytarabine
- **DRUG:** daunorubicin hydrochloride
- **DRUG:** dexamethasone
- **DRUG:** methotrexate
- **DRUG:** prednisone
- **DRUG:** vincristine sulfate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002499
- **Lead sponsor:** Grupo Argentino de Tratamiento de la Leucemia Aguda
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1990-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002499, "Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00002499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*